Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) Innovates Full-Scale PPE and Tech Solutions for Businesses and Individuals Managing Outbreak Risk for the Future
A lot of lessons were learned in 2020, not the least of which is that we have some major systemic issues regarding preparedness. The most alarming issue at the beginning of the global health crisis was how woefully inept the system for the production of personal protective equipment (PPE) — a BIG problem between suppliers, and their buyers.
The COVID-19 crisis underscored a need, that looking forward requires a MAJOR shift of how we operate for the years ahead.
At the beginning of this, PPE suppliers faced a ‘wild west’ of procurement on the market. It was a complete mess of empty boxes, unfulfilled orders and cargo planes landing at foreign airports, greeted by no one.
Early on in the crisis, Canada served as a brutal example of ill-preparedness, as government officials had to admit that $300 million worth of PPE supplies in the country’s National Emergency Stockpile System (NESS) had expired and gone to waste[1]—it had to be thrown out.
In a world without COVID-19, maybe this shortfall could be easily and quickly replaced. But once that world-changing event kicked off, suddenly governments all over the planet were scrambling to secure whatever supplies they could—often finding themselves later throwing out MILLIONS of masks and other supplies that were badly made from producers in places like China.[2]
Pre-2020, PPE was an afterthought in most people’s daily lives. TODAY… almost every single business is being required to supply their employees with protection, and enforce upon their customers compliance. Even with a vaccine coming available, the effects the current pandemic is likely 3-5 years away. Over the course of the coming months and decade to come businesses will be required to maintain vigilance in case of a next pandemic.
Almost a full year into this thing, and PPE shortages is STILL an issue.[3]
In short: We’ve crossed a Rubicon, and there’s no turning back.
Billionaire investor Ray Dalio saw this playing out very early on in April, stating, “the world will look different”. Among these observations, Dalio specifically predicted “priorities are going to shift [towards] healthcare and building the basics.”[4]
How we deal with health crises moving forward will look completely different than life prior to the outbreak. In order to get a handle on these threats moving forward, people and businesses are looking for protection—both through PPE and through tracing and other new forms of technology designed to contain the spread.
Creating a reliable domestic supply chain for PPE will undoubtedly require a complete overhaul of the system that was in place before this all began.[5]
Famously anti-tech billionaire investor Warren Buffett probably didn’t envision making PPE when he took a 10% interest in Chinese electric vehicle maker BYD (OTC:BYDDF) in 2008. But by the end of May 2020, the company was set for certification by the National Institute for Occupational Safety and Health (NIOSH) and a capability to produce 50 million N95 respirator masks per day.[6]
The move paid off, as the BYDDF share price has exploded over the course of the year.
However, calls for DOMESTIC supplies of PPE are growing louder.
But to avoid the same egregious issues in terms of materials and supplies, SECURITY needs to be airtight.
Addressing these very serious needs for change, a team in Canada came together to build a NEW system from top to bottom—not only in producing state-of-the-art PPE for institutions and individuals, but also in creating an entire environment aimed at enhancing the safety of ALL individuals from those making the equipment, those transporting it, and those wearing it.
Proprietary Healthcare Tech and PPE
Made Onshore
Meet Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC)
Rising to the occasion, the seeds for the idea behind Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) formed after a call to action in Vancouver was made by local business and community leaders to rapidly raise $150,000 to secure PPE supplies for an area hospital that was in dire need—within 12 business days those supplies landed.
That experience sparked a team of backers to form the company and assemble one of the most talented teams in the entire space.
The word “Maitri” comes from the Sanskrit word for “Compassion”.
After quickly discovering how bleak the situation was for healthcare institutions around the world in the early days of the crisis, a new mission was launched to form the ultimate team of healthcare specialists, tech innovators, and logistics experts to not only solve the issues of a broken system—but to completely disrupt it, revolutionize it, and perfect it.
Now thanks to their collective efforts and exceptional brain trust, Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) has put together a full platform that will allow all users to breathe easier… and safer.
Maitri Health has emerged as an exceptional integrated platform for all things related to the handling of the crisis: Including masks, shields, antimicrobial solutions, and soon swabs, tests, tracing and health management technology.
This isn’t just manufacturing business, but a full-suite answer to the entire global health care supply chain crisis.
According to Maitri’s leadership, Technology and R&D is the future of global health protection.
The company has relationships with the intention of creating partnerships and M&A opportunities that help their products collectively work together to provide any and all health care data associated with this fight to defeat current and future pandemics.
Maitri Health addresses current needs and delivers a long-term solution for supply chains well into the future.
Unlike during the early months of the crisis, Maitri Health’s proposal for buyers is a completely secure process.
This means tracking and logging each contact point of every single employee along the supply chain that may or may not have come in contact with each item, to securing other businesses and entities of all sizes through PPE for employees to proprietary tracing and security software.
But that’s not where their technological advancements end.
For example, the common surgical mask hasn’t changed for roughly 50 years. Maitri Health has redesigned both surgical and non-surgical masks (all ASTM Level 1, 2, 3 certified and Made in Canada) both in shape, comfort, and in materials used.
From testing kits, to tracing software and hardware, to anti-viral surface cleaners and hand sanitizers, to masks (surgical, non-surgical, and N95) and face shields, Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) has something to protect everyone.
BOTH GOVERNMENTS AND CORPORATIONS DRIVING DEMAND
As states and other communities brace for the impact of a possible predicted surge of positive COVID-19 test results, demand for PPE, test kits, and other materials is about to skyrocket.[7],[8],[9],[10]
Industry and governments are making major purchases, to ensure the economy can continue to operate without more widespread and substantial lockdowns.
This trend not projected to fizzle out any time soon. Analysts anticipate the US healthcare personal protective equipment market size to reach US$13.2 billion by 2027, expanding at a CAGR of 29.1% from 2020 to 2027[11]—and the Global market is set to grow to US$98.27 billion by the end of 2027[12].
5 Advantages That Position Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) for a Break-Out in the Months to Come.
- Sourcing and Supply Chain
Focus on distributing and growing domestic supply chain for PPE, Anti-Viral Solutions and Test Kits, for reliable transactions with countries and corporations in need. - Technology Transfer and R&D
Closing the circle between hardware and technology through partnerships and licensing agreements to better support the collection, storage and transfer of information for a complete PPE ecosystem. - Universal Supply Chain Control – Global Distribution
Strategic partnerships and supply agreements to bring the production of basic PPE and medical products produced in the Americas and Europe for global consumption, with local manufacturing and assembly in preparation for future biomedical emergencies. - Highest quality & reliability + sustainability
Production and distribution of products that are compliant, reliable and easy to access, with a focus on sustainable manufacturing and recycling practices. - World-class management team
Comprised of industry leaders in health, government, technology, capital markets and high-growth companies, including a former Canadian Minister of Health and a world infectious disease expert at Yale who works with the WHO and the CDC.
FACE MASKS / FACE SHIELDS
Maitri Health currently offers a series of next generation medical-grade masks called the 3D Mask, including those with ear loops, head straps, and other options to provide comfort, style and lab certified protection.
Users are already reporting back that these are more comfortable than the standard fare, while from a quality of materials standpoint, Maitri Health products come with a domestic safety assurance that most foreign suppliers cannot match.
They’re made better, and designed for longer use, using multiple layers and a better fit around the face and on the nose.
These masks are made in Canada, and production can be smoothly set up in the USA and abroad. Domestic production is key in this era, especially given all of the cases of faulty PPE that was ordered from China and shipped to the USA[13] , Canada[14] and Europe[15].
While China has claimed to have fixed the issue, it’s a much more secure option to have domestically produced equipment with onshore quality assures. The fear that comes with foreign made medical assets is real, and is impacting the cause[16].
Supplies of PPE has become a hot commodity in other nations, including not just masks, but face shields as well[17]. Back in March, German Chancellor Angela Merkel’s government banned the export of ALL protective medical equipment, including goggles, gowns, face shields, gloves and surgical masks[18].
Securing a domestic supply is incredibly important, not just in North America, but abroad as well.
In Canada, the calls are coming to come to terms with a need to shift towards manufacturing all types of PPE, including face shields.[19]
Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) is providing face shields along with its platform of face masks, and is taking orders at this time. Its Win-Shield is designed by healthcare and dental professionals to cover the face and head while adding a superior level of comfort.
The product is easy to assemble and comfortable for all day use, meant to change to perception of what it means to wear personal protective equipment.
TESTING SOLUTIONS
Maitri Health is providing a US made supplier of Saliva and Nasal Covid Test Kits called Diacarta. This biotech company has a test that ranks highly by the FDA for accuracy.
This solution to the need for high quality testing will be part Maitri Health Technologies’ broader vision of a full technology platform that tracks and provides intelligence to healthcare providers, government, corporations.
As part of Maitri’s digital strategy, testing provides a strong use case for data collection and eventual software driven predictive healthcare.
ANTIVIRAL SOLUTIONS
Maitri Health also currently offers a pair of antiviral solutions: Candid Clean Sanitizer and Clean Terra Antiviral Solution.
Certified as a safe product, Candid Clean Sanitizer is gentle on the hands, and non-greasy. With so many questionable hand sanitizers on the market made from alcohols that are rough on the hands and smell bad, Maitri’s team at Candid Clean designed a superior blend of quality ingredients and available fragrances.
CleanTerra Antiviral Solution is more effective than bleach and non-toxic, food safe non-corrosive and biodegradable. Envirocleanse, A Berkshire Hathaway Company, is a key partner that makes this effective daily disinfectant that can quickly and safely be used to eliminate pathogens on high touch surfaces such as counters, escalators, airplanes, buses, wheelchairs, site signage, gyms, desks, vehicle interiors, restrooms, hotel rooms, etc. CleanTerra is effective in the fight to keep areas safe without any risk of chemical poisoning to humans and does no damage to assets such as furniture or surfaces. This is unlike other cleaners on the market.
PRODUCTS IN DEVELOPMENT
On deck for Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) are a stream of products in development that the company plans for release by the end of November, including N95 Clear Masks, Swabs, Antigen and Anti-Body Tests, as well as a Technology Platform that involves Track and Trace, Inventory Management and Workplace Management.
Perhaps a key breakout among this group is that of the test kits, which are still in extremely high demand across North America and abroad.
These are being snapped up in massive numbers not only by governments, but by major businesses as well, such as Barrick Gold which bought 800,000 antibody test kits for use on its operations.[20]
As we will see, combining test kits and other diagnostic equipment to the company’s offerings could be a major game changer for Maitri Health.
Evaluating Maitri Health Among its Peers
It’s slightly difficult to compare Maitri Health with other producers of equipment in this space, because there is such a variety of competitors in the market. Keep in mind, that shortages still remain across several markets, so there’s still plenty of room to join the fray.
However it’s wise to start by looking at the BIGGEST entities in the PPE space, and how much they’ve gained from their 2020 low points to present (as of November 11, 2020).
| Company | Symbol | Share Price Today | % Gain Within 2020 | Mkt Cap |
| Maitri Health | N/A | N/A | N/A | N/A |
| Honeywell International | NYSE:HON | $199.29 | 92% | $139.8B |
| 3M Company | NYSE:MMM | $169.21 | 44% | $97.6B |
| MSA Safety Incorporated | NYSE:MSA | $143.87 | 65% | $5.6B |
*Latest share price taken from Yahoo! Finance on November 11, 2020
**All prices in USD
As we can see, there have been several respectable gains in the double digits, among the biggest players.
However, it’s in the microcaps to mid-cap levels that the much bigger gains are being witnessed. In the table below, only one company has a market cap over a billion dollars.
What these companies do have in common is a primary focus on healthcare safety supplies and diagnostic equipment. This is a smoking gun that points towards where the biggest gains are truly being made.
FOUR of these companies, Allied Healthcare Products, Owens & Minor, Alpha Pro Tech and Co-Diagnostics, have made gains of +2.7x —with CODX gaining +14x.
| Company | Symbol | Share Price Today | % Gain Within 2020 | Mkt Cap |
| Maitri Health | N/A | N/A | N/A | N/A |
| Yunhong CTI | NASDAQ:CTIB | $1.77 | 124% | $8.44M |
| Lakeland Industries | NASDAQ:LAKE | $20.22 | 91% | $161.35M |
| Allied Healthcare Products | NASDAQ:AHPI | $4.70 | 273% | $18.86M |
| Owens & Minor | NYSE:OMI | $23.04 | 459% | $1.69B |
| Alpha Pro Tech | NYSE:APT | $12.89 | 273% | $175M |
| Co-Diagnostics | NASDAQ:CODX | $13.30 | 1,362% | $375.98M |
*Latest share price taken from Yahoo! Finance on November 11, 2020
**All price in USD
Maitri Health Technologies Corp. (OTC: MHTCF / CSE: MTEC) has positioned itself to be a perfect hybrid of both the PPE space, and the diagnostics and tracing space.
The company already has a platform that includes face masks, antimicrobial solutions, and face shields. But soon, they’re prepared to launch N95 clear masks, swabs, tests, and tracing and detection technology.
Maitri Health’s All-Star Team
“ We have assembled an all-star team of leaders and innovators. Our team brings integrity, invaluable skills and future-forward vision to help drive our mission of building a global platform. The quality of people we’ve attracted is also a testament to our business model and their confidence in our success.”
– Andrew Morton CEO and Director of Maitri Health
CEO and Director – Andrew Morton
Morton is a seasoned global technology executive with a track record of successfully building and running innovative companies. He was SVP Global Sales for Zodiac Interactive, a private equity held software company focused on advanced software for Tier 1 Cable and Telecom providers. He headed up Broadband TV for Entone where he launched successful operations on multiple continents. Entone was acquired by Amino Communications (LON: AMO) where he served for several years post transaction on the senior executive team. Earlier in his career, Morton co-launched global operations for Comtrend Corporation, a leader in telecom hardware and software.
Chief Commercial Officer and Corporate Secretary – Marliss Yassin
Yassin is a CPA, CA with +15 years’ experience working with publicly listed companies. She has held finance management positions at various public companies, including an international industrial products company and mid-tier mining companies. Yassin gained extensive experience through her client engagements at Deloitte providing reporting, advisory and assurance services to publicly traded companies, primarily in the natural resources sector.
Strategic Advisor – Jodi Butts
A lawyer by trade and an entrepreneur at heart, Butts is a healthcare executive with a strong track record in driving positive change and growth within leading organizations. Previously, she served as Chief Executive Officer of Rise Asset Development and Senior Vice-President of Operations and Redevelopment at Mount Sinai Hospital.
Butts brings significant governance experience as she currently serves as an independent director at Canada Goose Holdings and Aphria, is a member of Dot Health board of directors and has held the Chair role on several Boards. She also holds several Board Advisory roles including with Bayshore Home Healthcare and the World Health Innovation Network at the University of Windsor.
Strategic Advisor – Dr. James Shepherd
Dr. Shepherd is one of the world’s foremost experts in infectious diseases. An associate professor of medicine at Yale School of Medicine, Dr. Shepherd’s global experience include his work as a special advisor to the World Health Organization. His recent history includes advising the Government of India on tuberculosis control, directing a research program in TB and HIV for the Centers for Disease Control and Prevention in Botswana, and assisting the University of Maryland start a large AIDS treatment program in Nigeria.
Strategic Advisor – Dr. Anne Snowdon
Dr. Snowdon is a leader in health system innovation and transformation and global supply chain infrastructure in healthcare. She’s currently Professor of Strategy and Entrepreneurship and Chair of the World Health Innovation Network (WIN), at the University of Windsor, Odette School of Business.
She currently leads a global network, SCAN Health, to disseminate new knowledge and enable cross jurisdiction learning to accelerate supply chain transformation across global health systems. She has published more than 140 research articles, papers and cases, has received more than $22 million in research funding, holds patents, and has commercialized a highly successful booster seat product for children traveling in vehicles.
Strategic Advisor – Sashko Despotovski
Despotovski is a seasoned investment banker and an active investor in both private and public companies. He has held posts within several funds and hedge funds in the investment banking capacity in USA and Canadian markets, as well as on the operational side as management and as a director for a number of companies. Despotovski holds advisory board seats at several international companies and is currently managing director of Hinna Park Capital in Norway.
Director – Gavin Cooper
Cooper is a Chartered Accountant with extensive experience in all aspects of corporate and financial management. For the past 35 years, he’s been providing strategic and financial advice and corporate administration services. He’s held senior positions with a number of public and private companies with local and international operations.
Director – Dr. Solomon (Sam) Pillersdorf
Dr. Pillersdorf has been involved in the mining sector for +10 years, including funding start-up mining companies and sourcing and funding resource claims. Dr. Pillersdorf was Head of Rheumatology Outpatients and Head of Rheumatology training at the McMaster University Medical Center.
Director – Tony Clement
Clement is a former Canadian federal politician and former Member of Canadian Parliament. He served in senior roles in Prime Minister Stephen Harper’s Cabinet for nearly a decade, as Health Minister, Industry Minister and President of the Treasury Board. As a business entrepreneur, he has also led information technology companies, and served on the board of directors on information technology and health care companies, having provided strategic advice both nationally and internationally.
Board Chair – Sav DiPasquale
DiPasquale is a senior executive with +30 years of experience in the pharmaceutical, biotechnology and transportation industries, and is currently President of the Canadian Pharmaceutical Distribution Network (“CPDN”). At CPDN, DiPasquale is responsible for overall operations, including the development and implementation of strategies to grow the organization’s membership and extend its unique service offering.
Previously he spent nearly 17 years at Glaxo Smith Kline in various senior positions, including VP Business Development and CIO.
Staff Editors
Equity Insider Team
DISCLAIMER:
Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor a recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Maitri Health advertising and digital media from the company directly. There may be 3rd parties who may have shares of Maitri Health and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Maitri Health which were purchased as a part of a private placement. MIQ will not buy or sell shares of Maitri Health for a minimum of 72 hours from the publication date on this website March 7, 2021, but reserve the right to buy and sell, and will buy and sell shares of Maitri Health at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above-mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market or through further private placements and/or investment vehicles.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
SOURCES:
[1] https://www.cmaj.ca/content/cmaj/early/2020/06/24/cmaj.200946.full.pdf
[2] https://www.vice.com/en/article/7kzae9/european-countries-are-throwing-out-rubbish-chinese-made-masks-and-coronavirus-tests
[3] https://www.bnnbloomberg.ca/fixing-the-ppe-shortage-should-top-biden-s-to-do-list-1.1520273
[4] https://markets.businessinsider.com/news/stocks/ray-dalio-bridgewater-associates-predicts-pandemic-boost-savings-self-sufficiency-2020-4-1029117199#
[5] https://www.supplychainbrain.com/articles/32170-qa-what-it-will-take-to-create-a-reliable-domestic-supply-chain-for-ppe
[6] https://www.fool.com/investing/2020/06/02/warren-buffett-backed-chinese-car-maker-turned-mas.aspx
[7] https://www.wgbh.org/news/local-news/2020/10/22/masks-gloves-and-other-protective-equipment-in-demand-as-mass-readies-for-possible-surge
[8] https://www.cbsnews.com/news/ppe-n95-mask-shortage-covid-19/
[9] https://www.citynews1130.com/2020/10/13/some-b-c-dentists-charging-covid-19-fee-to-cover-ppe-costs/
[10] https://news.ontario.ca/en/release/59065/ontarios-action-plan-protect-support-recover
[11] https://www.businesswire.com/news/home/20201019005365/en/United-States-Healthcare-Personal-Protective-Equipment-Market-Report-2020—ResearchAndMarkets.com
[12] https://www.allamadvisorygroup.com/ppeoutlook/
[13] https://www.latimes.com/world-nation/story/2020-04-10/china-beijing-supply-world-coronavirus-fight-quality-control
[14] https://globalnews.ca/news/6905351/coronavirus-china-canada-faulty-masks/
[15] https://www.aljazeera.com/news/2020/3/29/netherlands-recalls-defective-masks-imported-from-china
[16] https://www.propublica.org/article/foreign-masks-fear-and-a-fake-certification-staff-at-csl-plasma-say-conditions-at-donation-centers-arent-safe
[17] https://www.ft.com/content/efdadd97-aef5-47f1-91de-fe02c41a470a
[18] https://www.reuters.com/article/health-coronavirus-germany-exports-idUSL8N2AX3D9
[19] https://globalnews.ca/news/7406308/coronavirus-inside-supply-chain-crisis/
[20] https://www.ft.com/content/baf6f145-f2f9-42bd-ac75-9fd22f9b1091